Companies / BOC Sciences / Ozanezumab
BOC Sciences

Ozanezumab | BOC Sciences

(0) Write Review

Ozanezumab is a monoclonal antibody that targets Neurite Outgrowth Inhibitor (NOGO-A). Ozanezumab is undergoing cilinical trials for the treatment of amyotrophic lateral sclerosis and multiple sclerosis.

Reviews

(0) | Be the first to review this product
No reviews yet

ABOUT THE COMPANY

BOC Sciences
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars